Sequent Scientific has soared 16% to Rs 151, extending its past four days rally, after the promoters have converted warrants into equity shares at huge premium.
The stock opened at Rs 135 and has seen around 13,000 shares changing hands on the counter so far on BSE. The stock of pharmaceutical firm has zoomed 54% from Rs 97.95 on August 16 as compared to 1.4% fall in benchmark S&P BSE Sensex.
The stock opened at Rs 135 and has seen around 13,000 shares changing hands on the counter so far on BSE. The stock of pharmaceutical firm has zoomed 54% from Rs 97.95 on August 16 as compared to 1.4% fall in benchmark S&P BSE Sensex.
On August 14, the company has allotted 232,500 shares against conversion of same number of warrants at price of Rs 172 to promoters of the company, Sequent Scientific in a BSE filing.
The company allotted 116,250 equity shares each to Aqnus Capital LLP and Chayadeep Ventures LLP, it added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%